Humacyte (HUMA) Operating Expenses (2020 - 2026)
Humacyte (HUMA) posted quarterly Operating Expenses of $29.4 million for Q1 2026, up 24.17% year-over-year from $23.7 million in Q1 2025, and down 5.98% quarter-over-quarter from $31.3 million in Q4 2025.
Humacyte (HUMA) Operating Expenses (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Operating Expenses for 7 consecutive years, with $29.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 24.17% year-over-year to $29.4 million; the TTM figure through Mar 2026 stood at $115.9 million (up 3.93% YoY), while the FY2025 annual figure was $110.2 million, down 3.69% from the prior year.
- Operating Expenses slipped to $29.4 million in Q1 2026 per HUMA's latest filing, from $31.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $31.3 million in Q4 2025 and bottomed at $19.8 million in Q2 2022.
- Historically, Operating Expenses has averaged $25.9 million across 5 years, with a median of $26.2 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Expenses soared 34.79% — and 2025, when it fell 16.84%.
- Humacyte's Operating Expenses stood at $20.8 million in 2022, then advanced by 25.94% to $26.2 million in 2023, then climbed by 7.28% to $28.1 million in 2024, then climbed by 11.45% to $31.3 million in 2025, then decreased by 5.98% to $29.4 million in 2026.
- Business Quant data shows HUMA's Operating Expenses at $29.4 million in Q1 2026, $31.3 million in Q4 2025, and $25.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Humacyte | 158.12 Mn | 158.12 Mn | -825,000.00 | 27.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.40 Mn |
| Mar 31, 2026 | 29.43 Mn |
| Dec 31, 2025 | 31.30 Mn |
| Sep 30, 2025 | 25.14 Mn |
| Jun 30, 2025 | 30.03 Mn |
| Mar 31, 2025 | 23.70 Mn |
| Dec 31, 2024 | 28.09 Mn |
| Sep 30, 2024 | 30.23 Mn |
| Jun 30, 2024 | 29.50 Mn |
| Mar 31, 2024 | 26.58 Mn |
| Dec 31, 2023 | 26.18 Mn |
| Sep 30, 2023 | 24.62 Mn |
| Jun 30, 2023 | 26.73 Mn |
| Mar 31, 2023 | 22.51 Mn |
| Dec 31, 2022 | 20.79 Mn |
| Sep 30, 2022 | 23.53 Mn |
| Jun 30, 2022 | 19.83 Mn |
| Mar 31, 2022 | 22.00 Mn |
| Dec 31, 2021 | 21.80 Mn |
| Sep 30, 2021 | 20.78 Mn |